H. Versteeg
Hematology · 2003–2013
A researcher in the Science corpus: 3 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Hematology — 25 citations into it
- Genetics — 8 citations into it
Whom H. Versteeg trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from H. Versteeg's perspective
Ordered by how strongly the researchers H. Versteeg trusts endorse each paper. Same corpus, a different order for every researcher.
- Platelets in atherothrombosis (Nature Medicine)
- Development and validation of a predictive model for chemotherapy-associated thrombosis. (Blood)
- Prediction of venous thromboembolism in cancer patients. (Blood)
- Incidence of venous thrombosis in a large cohort of 66 329 cancer patients: results of a record linkage study (Journal of Thrombosis and Haemostasis)
- Efficacy and safety of recombinant human activated protein C for severe sepsis. (New England Journal of Medicine)
- Accumulation of Tissue Factor into Developing Thrombi In Vivo Is Dependent upon Microparticle P-Selectin Glycoprotein Ligand 1 and Platelet P-Selectin (Journal of Experimental Medicine)
- Platelet-collagen interaction: is GPVI the central receptor? (Blood)
- Aspirin for preventing the recurrence of venous thromboembolism. (New England Journal of Medicine)
- Drotrecogin alfa (activated) in adults with septic shock. (New England Journal of Medicine)
- Incidence of venous thromboembolism and its effect on survival among patients with common cancers. (Archives of Internal Medicine)
Their papers
- New fundamentals in hemostasis. (2013) — 1,039 citations
- Epidemiology of cancer-associated venous thrombosis. (2013) — 1,103 citations
- Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn's disease. (2003) — 756 citations